Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
492,937,031
-
Total 13F shares
-
396,250,140
-
Share change
-
-7,601,128
-
Total reported value
-
$8,506,918,630
-
Put/Call ratio
-
46%
-
Price per share
-
$21.45
-
Number of holders
-
355
-
Value change
-
-$172,335,832
-
Number of buys
-
183
-
Number of sells
-
175
Institutional Holders of Elanco Animal Health Inc - COMMON STOCK (ELAN) as of Q2 2020
As of 30 Jun 2020,
Elanco Animal Health Inc - COMMON STOCK (ELAN) was held by
355 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
396,250,140 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, PRIMECAP MANAGEMENT CO/CA/, JANUS HENDERSON GROUP PLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, Aristotle Capital Management, LLC, STATE STREET CORP, UBS Group AG, and AMUNDI PIONEER ASSET MANAGEMENT INC.
This page lists
355
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.